title: Treatments for EGFR Mutation-Positive (M+) NSCLC Patients - A Network Meta-Analysis (NMA) by Mutation Type.
authors.affiliation: Royal Marsden Hospital, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Popat
authors.affiliation: Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Lungershausen
authors.affiliation: Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Griebsch
authors.affiliation: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Marten
authors.affiliation: Guangdong Lung Cancer Institute, Guangzhou, China.
authors.forename: Y L
authors.initials: YL
authors.lastname: Wu